Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria
There are ~660,000 deaths from severe malaria each year. Intravenous artesunate (i.v. ARS) is the first‐line treatment in adults and children. To optimize the dosing regimen of i.v. ARS, the largest pooled population pharmacokinetic study to date of the active metabolite dihydroartemisinin (DHA) was...
Saved in:
Main Authors: | S G Zaloumis (Author), J Tarning (Author), S Krishna (Author), R N Price (Author), N J White (Author), T M E Davis (Author), J M McCaw (Author), P Olliaro (Author), R J Maude (Author), P Kremsner (Author), A Dondorp (Author), M Gomes (Author), K Barnes (Author), J A Simpson (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria
by: Walter RJ Taylor, et al. -
Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa
by: Yoel Lubell, et al.
Published: (2011) -
Bioequivalence of Two Intravenous Artesunate Products with Its Active Metabolite Following Single and Multiple Injections
by: Qigui Li, et al.
Published: (2011) -
In vitro and in vivo Effects of Artesunate on Echinococcus granulosus Protoscoleces and Metacestodes
by: Wen L, et al.
Published: (2020) -
Anti-tumor mechanism of artesunate
by: Xiaoyu Fan, et al.
Published: (2024)